Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 22, 2026
ERShares Private-Public Crossover ETF (XOVR): Blending Public Innovators with Private-Market Exposure

ERShares Private-Public Crossover ETF (XOVR): Blending Public Innovators with Private-Market Exposure

Key Takeaways

  • XOVR is an actively managed crossover strategy that pairs public "entrepreneur-led" large caps with a measured private-equity sleeve, most notably an indirect SpaceX position.
  • The portfolio is growth-heavy, with technology (roughly 37%), communication services (about 26%), and healthcare (about 20%) dominating sector exposure.
  • The fund carries a 0.75% expense ratio and held roughly $2.2 billion in net assets as of mid-2026, spread across approximately 33 holdings.
  • Recent trading has been range-bound rather than trend-driven, with the fund consolidating between its 52-week band of about $16.37 and $21.78.
  • Structural themes include AI computing, cloud and cybersecurity, fintech, and private-market innovation, anchored by a policy-capped private sleeve of up to roughly 15%.

Understanding the ERShares Private-Public Crossover ETF (XOVR)

The ERShares Private-Public Crossover ETF seeks long-term capital appreciation by combining two distinct sleeves within a single daily-liquid exchange-traded fund (ETF). The public sleeve is anchored to the ER30TR Index, a proprietary, rules-based basket of 30 U.S. large-cap companies screened through a venture-capital-style lens that emphasizes entrepreneurial leadership, innovation density, and product-market fit. Complementing this foundation, the fund maintains a policy-capped private sleeve—generally up to about 15% of net asset value (NAV)—that currently provides indirect exposure to late-stage private companies, most prominently SpaceX.

The fund is non-diversified and concentrated, holding roughly 33 securities with the top ten representing well over half of assets. Its largest public positions include NVIDIA, Alphabet, Meta Platforms, AppLovin, Reddit, Robinhood Markets, and Fortinet, with a separate special purpose vehicle (SPV) providing the SpaceX exposure. The gross and net expense ratio is 0.75%. To get a sense of comparable holdings across these themes, I also checked this using Tickeron’s AI Screener.

Industry and Thematic Landscape

XOVR sits at the intersection of several powerful market themes. Its public book is heavily weighted to semiconductor and software leaders tied to artificial-intelligence infrastructure, cloud computing, and cybersecurity, while its communication-services exposure captures digital-advertising and social-platform economics. The private sleeve adds exposure to the space economy through SpaceX, a company whose commercial scale—led by its Starlink satellite-internet business—has drawn significant investor attention.

The broader macroeconomic backdrop remains a key variable. Higher-for-longer interest-rate expectations tend to pressure long-duration growth equities by raising the discount rate applied to future earnings, which explains part of the fund's choppiness. At the same time, resilient corporate earnings across mega-cap technology names and sustained enthusiasm around AI capital spending have provided a counterweight. For a concentrated, growth-oriented portfolio with a price-to-earnings multiple well above the broader market, these macro and sentiment shifts translate directly into share-price volatility. From what I see, this dynamic makes the fund particularly sensitive to shifts in both public-market leadership and private-valuation updates.

Performance and Positioning Snapshot

Over the trailing 30-day window, XOVR advanced roughly 7%, while over the most recent three-month stretch it gained about 5%—a modest, non-trending profile consistent with a fund consolidating inside a wider trading range. The path has been uneven: the ETF climbed toward the low-$21 area in early July, retreated to the mid-$18 range later that month as growth and semiconductor leadership wobbled, then recovered to about $20 as large-cap technology stabilized.

This behavior closely tracks the fund's concentrated exposure. Moves in NVIDIA and other AI-infrastructure holdings tend to dominate daily attribution given their top-heavy weights, while sentiment around the private sleeve—particularly SpaceX—can add a distinct layer of volatility. The private position is valued periodically rather than continuously, which can cause NAV to lag rapid shifts in public-market enthusiasm and can occasionally widen the ETF's bid-ask spread relative to conventional funds. I'm watching this closely as it influences how the fund trades relative to its underlying holdings.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape XOVR's trajectory through the remainder of 2026. The path of interest rates and inflation expectations remains central, because a concentrated growth portfolio is especially sensitive to shifts in the discount rate applied to future earnings. AI capital-expenditure trends and semiconductor demand will continue to drive the fund's largest public positions, while digital-advertising growth and fintech adoption influence the communication-services and financials sleeves.

The private sleeve adds a distinct set of considerations. Investors should monitor developments around SpaceX—including any progress toward a public listing, valuation marks on the SPV, and the fund's ability to manage liquidity within a daily-redeemable structure. Regulatory scrutiny of private-asset valuation and ETF liquidity management could also evolve. On the risk side, concentration, elevated valuations, and the potential for sharp sector rotation all remain meaningful; on the opportunity side, sustained AI investment and broader private-market access continue to support the fund's core investment theme. As always, the fund's concentrated, growth-oriented construction means investors should expect volatility above that of a diversified equity index.

Using Tickeron’s AI Screener for Deeper Analysis

In my own research process, Tickeron's AI Screener has proven helpful for quickly scanning thousands of securities with technical indicators, fundamentals, volatility measures, and AI-generated signals. It allows efficient filtering by industry and theme, which is useful when evaluating exposure in growth-oriented strategies like XOVR and tracking how leadership shifts across technology, communication services, and related sectors. This kind of tool helps surface comparable names and monitor rotation without manual effort across multiple data points.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: XOVR

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


XOVR in upward trend: 10-day moving average crossed above 50-day moving average on August 14, 2026

The 10-day moving average for XOVR crossed bullishly above the 50-day moving average on August 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where XOVR advanced for three days, in 296 of 338 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

The Aroon Indicator entered an Uptrend today. In 249 of 288 cases where XOVR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 59 of 64 cases where XOVR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XOVR as a result. In 68 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The Moving Average Convergence Divergence Histogram (MACD) for XOVR turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 36 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOVR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

XOVR broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Meta Platforms (NASDAQ:META), Tesla (NASDAQ:TSLA), Oracle Corp (NYSE:ORCL), Arista Networks Inc (NYSE:ANET), Crowdstrike Holdings Inc (NASDAQ:CRWD), Salesforce (NYSE:CRM), Datadog (NASDAQ:DDOG), Everpure Inc. (NYSE:PSTG).

Industry description

The investment seeks long-term capital appreciation. The fund invests primarily in equity securities of mid and large capitalization companies traded on the NASDAQ, the New York Stock Exchange or other major U.S. exchanges. Equity securities include common stocks, preferred stocks, convertible preferred stocks, American Depositary Receipts (ADRs) (sponsored only) and Global Depositary Receipts (GDRs) (sponsored only). The fund is non-diversified.

Market Cap

The average market capitalization across the ERShares Private-Public Crossover ETF (XOVR) ETF is 508B. The market cap for tickers in the group ranges from 6.58B to 5.37T. NVDA holds the highest valuation in this group at 5.37T. The lowest valued company is TTD at 6.58B.

High and low price notable news

The average weekly price growth across all stocks in the ERShares Private-Public Crossover ETF (XOVR) ETF was 1%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was 23%. CRWD experienced the highest price growth at 15%, while DKNG experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the ERShares Private-Public Crossover ETF (XOVR) ETF was 92%. For the same stocks of the ETF, the average monthly volume growth was 122% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 62
Price Growth Rating: 50
SMR Rating: 47
Profit Risk Rating: 60
Seasonality Score: -12 (-100 ... +100)
View a ticker or compare two or three
XOVR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeGrowth

Profile
Details
Category
Large Growth
Address
EntrepreneurShares Series TrustC/O WESTON CAPITAL ADVISORS, LLCWellesley Hills
Phone
(781) 239-4446
Web
www.ershares.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.